This appears to be a general trend in mice as transcription of EphB2 was also elevated in STAMTM mice, a newly developed animal model of non-alcoholic steatohepatitis (NASH) compared to control animals (data not shown). The gene discussed is EPHB2; the disease is metabolic dysfunction-associated steatohepatitis.